Abstract
Intrathecal drug delivery systems (IDDS) are commonly utilized for many refractory chronic pain conditions and cancer associated pain. Manufacturer recommendations are available for physicians and MRI facilities to review prior to obtaining a scan1. We discuss a case in which IDDS malfunction occurred following MRI, despite following manufacturer instructions prior to and after MRI, resulting in profound medication overdose.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Paper Title
Journal
Date
